Abstract
Chronic stress affects immune function and hormonal signaling and has been hypothesized to be associated with breast cancer, although results from the few prior studies are mixed and have not examined potential differences by estrogen receptor (ER) status. Using the Women’s Health Initiative Study, we included 76,951 postmenopausal women followed for events for a median of 16.7 years to investigate the association between baseline self-reported stressful life events and incident breast cancer by ER status and whether the association was modified by social support. We generated Cox proportional hazards models adjusting for demographic, clinical, lifestyle/behavioral, and social factors to estimate hazard ratios (HR) and 95% confidence intervals (95%CI). The mean age was 63 (SD 7.3), and majority of participants were White race (83.5%) and married or in a marriage-like relationship (63.0%). In analyses stratified by ER status, there was no relationship between stressful life events and ER-positive breast cancer. In contrast, compared to women in the lowest quartile, those in higher quartiles had an increased risk of ER-negative breast cancer, where those in quartile 4 had the highest risk (Quartile 4 vs Quartile 1; HR=1.30; 95%CI 1.01–1.68; Ptrend=0.050). Moreover, associations were stronger for the highest versus lowest quartile of stressful life events among widowed women (HR=2.39; 95%CI 1.29–4.44; Pinteraction<0.001). Association between stressful life events and ER-negative breast cancer was not modified by social support. In this cohort of postmenopausal women, higher experiences of pre-diagnostic stressful life events were associated with increased risk of ER-negative breast cancer.
Keywords: Psychosocial Stress, Stressors, Estrogen Receptor, Breast Cancer, Social Support
Introduction
Epidemiologic studies have linked psychosocial stress to disease risk, progression, and mortality (1–3). Psychosocial stress encompasses the dynamic interaction between individuals and their social environment, where adverse external events result in feelings of threat and subsequent emotional tension or discomfort (1,2,4). Chronic exposure to stress has been documented to influence inflammation, hormonal changes, suppressed immune function, and endothelial dysfunction (4–6). Additionally, studies have linked chronic psychosocial stress to excess adiposity, emotional distress, and engagement in unhealthy behaviors (e.g., tobacco use, alcohol consumption) (1,2). Prior studies have documented an association between chronic experiences of psychosocial stress and increased risk of chronic disease and poor mental health (2,7,8).
Although many mechanisms suggest that chronic exposure to stress may be associated with breast cancer, results from prior studies are inconsistent with many reporting a null association for breast cancer risk (5,9–12). However, breast cancer is a heterogeneous disease, where studies have established risk factors can vary by estrogen receptor (ER) status, such as breastfeeding and time since last pregnancy (13–15). Additionally, recent descriptive studies have shown that less established risk factors such as experiences of social adversity are associated with increased incidence of ER-negative breast cancer (16,17). However, study of the relationship between psychosocial stress and cancer remains limited.
Studies have documented that greater social support provide resources during periods of stress (i.e., reducing negative feelings about oneself), thereby buffering the harmful effects psychosocial stress may have on disease risk (2,18,19). However, investigation of whether social support modifies the association between psychosocial stress and breast cancer remains limited.
The present study investigated the relationship between stressful life events, which measures the accumulation and perceived severity of a stressful event, and incident breast cancer by ER status among a large cohort of postmenopausal women. We further evaluated whether this association is modified by social support. Our findings aim to provide evidence on whether chronic psychosocial stress and incident breast cancer vary by ER status. Based on findings on social adversity and breast cancer, we hypothesized that higher experiences of stressful life events would be associated with increased risk of ER-negative breast cancer. We further hypothesized that the stressful life events-ER-negative breast cancer relationship will be buffered with high social support.
Methods
Study Cohort
The present study used data from the Women’s Health Initiative (WHI). WHI is a large prospective cohort study composed of clinical trials (including hormone therapy [2 trials], low-fat diet patterns, and vitamin D and calcium supplementation) and an observational study. Details of the WHI study has been previously described (20). Briefly, between 1993 and 1998 postmenopausal women aged 50-79 years were recruited from forty clinical sites across the U.S. into one or more randomized clinical trials (WHI-CT: n=68,132) or the observational study (WHI-OS: m=93,676). WHI-OS included women that were either ineligible or did not want to participate in the WHI-CT. The WHI ended in 2003-2004, and participants were invited to continue follow-up in the WHI Extension Study 1 (2005-2010) and Extension Study 2 (2010-2015). The study was conducted according to the Declaration of Helsinki. All participants provided written informed consent and Institutional Review Board approval were obtained at each study institution.
The present study included women participating in the WHI-OS only. Women were excluded if they were previously diagnosed with cancer (n=12,827), diagnosed with non-invasive breast cancer (n=1,169), no information or unknown breast cancer estrogen receptor and/or progesterone receptor status (n=377), missing information on baseline stressful life events (n=1,701), and missing follow-up data (n=382). To account for potential undiagnosed breast cancer at baseline, women with a breast cancer diagnosis within the first year of follow-up were excluded (n=269). Our final analytical cohort included 76,951 individuals (Supplemental Figure 1).
Measures
Participants’ experiences of stressful life events and social support were collected via questionnaire (Supplemental Table 1) at baseline. The life events questionnaire was adapted from the Beta-Blocker Heart Attack Trial (21). At baseline, participants indicated whether any of eleven life changes had occurred over the past year. Sample items included, “spouse died”, “physically abused”, and “major conflict with children or grandchildren.” Participants were then asked to appraise each of the eleven life events that occurred based on the degree of upset that it caused on a scale of 1 (did not upset me) to 3 (upset me very much), where the total score ranged from 0 to 33, with higher scores indicate greater experiences of stressful life events. Scores were categorized into approximate quartiles (Quartile 1: ≤1; Quartile 2: 2; Quartile 3: 3-4; and Quartile 4: >4 or more) based on the response distribution.
Social support was evaluated using the 9-items from the Medical Outcomes Study Social Support Survey among participants that completed the questionnaires (n=75,196) (22). Participants were asked to rate their perceived social support on a scale of 1 (none of the time) to 5 (all of the time), whether specific types of support (emotional support, affection, tangible support, and positive interaction) were available. The total score ranged from 9 to 45, with higher scores indicating greater social support. Social Support scores were categorized into approximate quartiles (Quartile 1= ≤32, Quartile 2= >32-≤37, Quartile 3= >37-≤43, and Quartile 4= >43.) based on the distribution of responses.
Covariates
Social function, which measures the ability to participate in desired social activities without limitation was measured using the RAND 36-Item Health Survey Quality of Life subscales on social functioning (23). Scores range from 0 to 100 with a higher score indicating a more favorable health state. Scores were categorized into approximate tertiles (Tertile 1: <87.5, Tertile 2: ≥87.5 and <100, and Tertile 3: 100) based on distributions of participants’ scores. Social strain was assessed using the 4 items derived from previously validated measure of negative aspects of social relationships (24). Participants rated their perceived social strain on a scale from 1 (none) to 5 (all), yielding a social strain score ranging 4-20, with higher scores indicating greater social strain. Scores were categorized into approximate tertiles (Tertile 1: ≤5, Tertile 2: 6-7, and Tertile 3: ≥8) based on the study population distribution. Finally, depressive symptoms were measured using the 8-item Burnham short version of the Center for Epidemiologic Studies-Depression (CES-D) (25). Scores ranged from 0 to 1 with a higher score indicating a greater depressive symptomatology.
We created a causal diagram guided by conceptual models of psychosocial stress and cancer to identify potential confounders of the association between stressful life events and incident breast cancer (4,26). We grouped covariates into four groups of factors collected at baseline: demographic, health and clinical, lifestyle/behavioral, and social factors. Demographic factors included age at study entry (continuous), race/ethnicity (Alaskan Native/American Indian, Asian/Pacific Islander, Black, Hispanic/Latina, White, other/unknown), educational attainment (less than high school, high school diploma/GED, vocational/training school or Associate/some college, college graduate, graduate/professional education), annual family income (<$35,000, $35,000 to $49,999, $50,000 to $74,999, ≥ $75,000 or don’t know), and marital/relationship status (never married, married or marriage-like relationship, divorced/separated or widowed). Health and clinical factors included: body mass index [weight(kg)/height(m)2] (continuous), age at menarche (<12, 12-13, or ≥14), age at first birth (no term pregnancy, <20, 20-29, or ≥30), parity (never pregnant/no term pregnancy, 1, 2, 3, 4, or ≥5), benign breast disease (yes or no), age at menopause (continuous), hysterectomy (yes or no), bilateral oophorectomy (yes or no), oral contraceptive use duration (continuous), hormone therapy usage (unopposed estrogen and/or estrogen plus progesterone) (never used, past user, or current user), family history of breast cancer (yes or no), and depressive symptoms (continuous). Lifestyle/behavioral factors included number of months breastfed (never, 1-6, 7-12, ≥13), pack years of smoking (continuous), alcohol serving per week (continuous), and recreational physical activity (metabolic equivalent-hours per week) (continuous). Social factors included: social strain (in tertile) and social function (in tertile). Moreover, an estimated invasive female breast cancer risk score was calculated based on the Gail model derived from the following covariates: age, race/ethnicity, age at menarche, age at first live child, number of first-degree relatives with breast cancer, and the number of previous breast biopsy examinations. Details on the Gail model has been previously described (27,28).
Breast Cancer
Participants were contacted annually in the WHI-OS arm to obtain information on clinical outcomes using in-person, mailed, or telephone questionnaires (20,29). Information from medical records were forwarded to the WHI coordinating center for central adjudication and coding of breast cancer characteristics. Breast cancer was confirmed centrally by a trained physician adjudicator following review of pathology reports and medical records. ER and PR status was determined by local laboratory confirmation.
Statistical Analysis
Cox proportional regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (95%CI) for the association between stressful life events and incident breast cancer overall and by ER status. Time to breast cancer was computed from one year after enrollment date to first breast cancer diagnosis. Participants without breast cancer or absent ER status being evaluated were censored at date of last follow-up visit or death. Covariates were selected if their inclusion in the models resulted in a 10% change in estimated main effect of stressful life events. In Model 1, we adjusted for Gail model risk score, body mass index, parity, age at menopause, pack years of smoking, number of months of breastfeeding, alcohol servings per week, total energy expenditure from recreational physical activity, family income, marital/relationship status, and hormone therapy. Based on prior findings indicating mental health and social factors are associated with stressful life events and may influence breast cancer risk, in Model 2 we adjusted for Model 1+ depressive symptoms, social strain, and social function (16,17,30–34). The variables depressive symptoms, social strain, and social function may be possible mediators, which could be a response to experiences of stressful life events, or actual confounders, thereby utilizing this sequential modeling approach will allow for evaluating the absence and presence of these covariates. Using Model 2, we further examined interaction by income, marital/relationship status, social strain, and social support. Tests for interaction were performed using the likelihood ratio tests comparing model with the cross-product terms to one without. Tests for trend was performed across quartiles of stressful life events by entering the categories as a continuous variable. We examined the assumption of proportional hazards by including an interaction between stressful life events and the log of time in the Cox proportional hazards models. There was no evidence that the assumption of proportional hazards was violated. All statistical tests were two-tailed, and analyses were performed using SAS version 9.4.
Data Availability Statement
The datasets generated during this study may be made available upon appropriate request from the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) at the National Heart, Lung, and Blood Institute (Bethesda, MD). Additionally, the analytical methods for this study are available from the corresponding author upon appropriate request.
Results
Women in the highest quartile of stressful life events were younger, more likely to be Black racial group, less likely to be married or in a marriage-like relationship, and lower annual family income than the lowest quartile (Table 1). They were also less likely to engage in recreational physical activity, have a higher body mass index, and greater pack years of smoking. Moreover, those in the highest quartile were more likely to experience greater social strain, and depressive symptoms, as well as lower social support.
Table 1.
Selected Baseline Participant Characteristics by Stressful Life Events Category, in the Women’s Health Initiative, (n=76,951)
| Stressful Life Events a | ||||
|---|---|---|---|---|
|
| ||||
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |
| Age, y, mean ± SD | 63.98 ± 7.28 | 63.81 ± 7.29 | 62.73 ± 7.31 | 62.15 ± 7.31 |
| Race/Ethnicity, % | ||||
| Alaskan Native/American Indian | 0.3 | 0.4 | 0.4 | 0.7 |
| Asian/Pacific Islander | 3.7 | 3.0 | 2.7 | 2.4 |
| Black | 5.7 | 6.9 | 8.8 | 12.6 |
| Hispanic/Latina | 3.0 | 2.9 | 3.9 | 6.1 |
| White | 86.1 | 85.6 | 82.5 | 76.4 |
| Other/unknown | 1.2 | 1.2 | 1.7 | 1.8 |
| Highest Educational Attainment, % | ||||
| Less than high school | 4.3 | 4.2 | 4.9 | 7.0 |
| High School Diploma/GED | 16.2 | 16.3 | 16.7 | 16.7 |
| Vocational/Training School or Associate/Some college | 33.5 | 35.9 | 38.4 | 40.8 |
| College graduate | 12.9 | 12.1 | 10.7 | 9.6 |
| Graduate/Professional education | 33.1 | 31.5 | 29.3 | 25.9 |
| Marital/Relationship status, % | ||||
| Never married | 5.5 | 4.9 | 3.8 | 3.3 |
| Married or Marriage-like relationship | 66.3 | 65.4 | 63.1 | 53.5 |
| Divorced or separated | 12.6 | 13.8 | 16.4 | 22.7 |
| Widowed | 15.6 | 15.9 | 16.7 | 20.5 |
| Annual family income, % | ||||
| <$35,000 | 32.9 | 35.5 | 38.1 | 47.7 |
| $35,000 to $49,999 | 19.8 | 20.3 | 19.8 | 18.1 |
| $50,000 to $74,999 | 21.2 | 20.1 | 19.9 | 16.6 |
| ≥ $75,000 | 23.0 | 21.1 | 19.2 | 14.3 |
| Don’t Know | 3.1 | 3.0 | 3.0 | 3.3 |
| Family history of female relative with breast cancer, % | 40.1 | 39.1 | 39.3 | 37.2 |
| Age at menarche, % | ||||
| <12 | 20.6 | 21.5 | 22.6 | 24.4 |
| 12-13 | 56.4 | 55.9 | 55.0 | 52.5 |
| ≥14 | 23.0 | 22.6 | 22.4 | 23.1 |
| Age at menopause, y, mean ± SD | 48.65 ± 6.07 | 48.42 ± 6.25 | 48.03 ± 6.43 | 47.57 ± 6.67 |
| Body mass index, mean ± SD b | 26.62 ± 5.51 | 26.94 ± 5.64 | 27.46 ± 5.85 | 28.37 ± 6.43 |
| Total energy expenditure from recreational physical activity (MET-hours/week), mean ± SD | 14.77 ± 14.67 | 13.91 ± 14.17 | 13.22 ± 13.91 | 12.51 ± 14.47 |
| Parity | ||||
| Never been pregnant/ no term pregnancy | 14.0 | 13.2 | 11.3 | 9.7 |
| 1 | 8.9 | 8.8 | 8.9 | 9.4 |
| 2 | 27.1 | 26.4 | 26.4 | 25.2 |
| 3 | 24.4 | 24.2 | 24.4 | 23.9 |
| 4 | 13.9 | 14.4 | 14.7 | 15.6 |
| ≥5 | 11.7 | 13.0 | 14.3 | 16.2 |
| Age at first birth, y, % | ||||
| Never had term pregnancy | 3.3 | 3.4 | 3.1 | 3.4 |
| <20 | 11.0 | 12.5 | 15.8 | 19.5 |
| 20-29 | 75.5 | 74.7 | 72.5 | 68.6 |
| ≥30 | 10.2 | 9.4 | 8.6 | 8.5 |
| Unopposed Hormone therapy Usage, % c | ||||
| Never used | 39.7 | 38.6 | 37.6 | 40.8 |
| Past user | 13.3 | 13.8 | 13.7 | 14.3 |
| Current user | 47.0 | 47.6 | 48.7 | 44.9 |
| Number of months breastfed, % | ||||
| Never breastfed | 50.5 | 49.5 | 48.2 | 47.4 |
| 1-6 months | 24.9 | 25.6 | 26.5 | 26.8 |
| 7-12 Months | 10.9 | 11.2 | 11.2 | 11.5 |
| ≥13 | 13.7 | 13.7 | 14.1 | 14.3 |
| Oral contraceptive use duration, y, mean ± SD | 2.10 ± 4.22 | 2.08 ± 4.19 | 2.25 ± 4.27 | 2.25 ± 4.30 |
| Hysterectomy | ||||
| Yes | 36.5 | 39.4 | 41.5 | 44.3 |
| No | 63.5 | 60.6 | 58.5 | 55.7 |
| Bilateral Oophorectomy | ||||
| Yes | 17.7 | 19.5 | 19.3 | 19.9 |
| No | 82.3 | 80.5 | 80.7 | 80.1 |
| Benign Breast Disease, % | ||||
| Yes | 22.3 | 22.7 | 21.9 | 22.2 |
| No | 77.7 | 77.3 | 78.1 | 77.8 |
| Pack years of smoking, mean ± SD | 9.20 ± 17.82 | 9.67 ± 18.21 | 10.02 ± 18.34 | 10.52 ± 19.10 |
| Alcohol Servings Per week, mean ± SD | 2.61 ± 5.10 | 2.59 ± 5.09 | 2.46 ± 5.50 | 2.21 ± 5.07 |
| Social Strain, % d | ||||
| Tertile 1 | 55.1 | 47.0 | 36.9 | 26.8 |
| Tertile 2 | 25.3 | 27.7 | 28.2 | 25.6 |
| Tertile 3 | 19.6 | 25.3 | 34.9 | 47.6 |
| Social Support, % e | ||||
| Quartile 1 | 22.3 | 24.8 | 30.6 | 40.3 |
| Quartile 2 | 22.8 | 23.5 | 23.9 | 23.4 |
| Quartile 3 | 29.7 | 29.9 | 27.8 | 23.3 |
| Quartile 4 | 25.2 | 21.8 | 17.7 | 13.0 |
| Social Function, % f, | ||||
| Tertile 1 | 13.9 | 18.9 | 26.1 | 38.6 |
| Tertile 2 | 9.6 | 11.8 | 12.9 | 14.7 |
| Tertile 3 | 76.5 | 69.3 | 61.0 | 46.7 |
| Depressive symptoms, score, mean ± SD g | 0.01 ± 0.07 | 0.03 ± 0.10 | 0.04 ± 0.13 | 0.11 ± 0.21 |
| Gail model score for breast cancer risk, mean ± SD h | 1.83 ± 0.96 | 1.82 ± 1.00 | 1.74 ± 1.01 | 1.65 ± 1.03 |
Abbreviations: SD, standard deviation; GED, general equivalency diploma; MET, metabolic equivalent of task
Stressful life events: Quartile 1= ≤1, Quartile 2= 2, Quartile 3= 3-4, Quartile 4= >4.
Body mass index was calculated as weight (kg)/height (m)2
Hormone therapy includes unopposed estrogen and/or estrogen plus progesterone)
Social Strain score: Tertile 1= ≤5, Tertile 2= 6-7, Tertile 3= ≥8.
Social Support score: Quartile 1= ≤32, Quartile 2= >32-≤37, Quartile 3= >37-≤43, Quartile 4= >43 (n=75,196)
Social Functioning score: Tertile 1= <87.5, Tertile 2= ≥87.5 - <100, Tertile 3= 100.
Higher score indicating a greater likelihood of depression
Gail model risk of breast cancer score (age, ethnicity, age at menarche, age of the mother at the birth of her first live child, number of first-degree relatives with breast cancer, and the number of previous breast biopsy examinations)
In multivariable analysis, no association was observed between experiences of stressful life events and incident breast cancer for both models (Table 2). When stratified by ER status, compared to women in the lowest quartile, those in higher quartiles had an increased risk of ER-negative breast cancer in the fully adjusted model, where those in quartile 4 had the highest risk (Model 2: Quartile 4 vs Quartile 1; HR=1.30; 95%CI 1.01–1.68; Ptrend=0.050) (Table 3). No association was observed for ER-positive breast cancer.
Table 2.
Adjusted-Hazard Ratios for the Associations between Stressful Life Events and Incident Breast Cancer in the Women’s Health Initiative, (n=76,951)
| Incident breast cancer events | Model 1 HR (95%CI) |
Model 2 HR (95%CI) |
|
|---|---|---|---|
| Stressful life events a | |||
| Quartile 1 | 1,561 | Reference | Reference |
| Quartile 2 | 1,518 | 1.07 (0.99, 1.16) | 1.07 (0.99, 1.15) |
| Quartile 3 | 778 | 1.00 (0.92, 1.10) | 1.01 (0.92, 1.11) |
| Quartile 4 | 827 | 1.00 (0.91, 1.09) | 1.01 (0.92, 1.12) |
| P trend | 0.772 | 0.944 |
Stressful life events: Quartile 1= ≤1, Quartile 2= 2, Quartile 3= 3-4, Quartile 4= >4.
Model 1: Adjusted for Gail model score for breast cancer risk (age, race/ethnicity, age at menarche, age of the mother at the birth of her first live child, number of first-degree relatives with breast cancer, and the number of previous breast biopsy examinations), parity, body mass index, age at menopause, pack years of smoking, number of months breastfed, alcohol servings per week, total energy expenditure from recreational physical activity, annual family income, marital/relationship status, hormone therapy.
Model 2: Model 1+, depressive symptoms, social strain, social function
Abbreviations: 95%CI, 95% confidence interval; HR, hazard ratio; ER-, estrogen receptor negative, H=ER+, estrogen receptor positive; MET, metabolic equivalent of task
Note: Unopposed Hormone therapy usage includes unopposed estrogen and/or estrogen plus progesterone
Table 3.
Adjusted Hazard Ratios for the Associations between Stressful Life Events and Incident Breast Cancer by Estrogen Receptor Status in the Women’s Health Initiative, (n=76,951)
| Incident ER− Breast cancer events | Model 1 HR (95%CI) |
Model 2 HR (95%CI) |
Incident ER+ breast cancer events | Model 1 HR (95%CI) |
Model 2 HR (95%CI) |
|
|---|---|---|---|---|---|---|
| Stressful life events a | ||||||
| Quartile 1 | 196 | Reference | Reference | 2,099 | Reference | Reference |
| Quartile 2 | 213 | 1.18 (0.95, 1.45) | 1.21 (0.98, 1.50) | 1,965 | 1.06 (0.97, 1.15) | 1.05 (0.96, 1.14) |
| Quartile 3 | 110 | 1.10 (0.85, 1.42) | 1.19 (0.92, 1.54) | 1,074 | 0.99 (0.90, 1.09) | 0.98 (0.89, 1.09) |
| Quartile 4 | 128 | 1.17 (0.92, 1.50) | 1.30 (1.01, 1.68) | 1,152 | 0.97 (0.88, 1.07) | 0.97 (0.87, 1.08) |
| P trend | 0.255 | 0.050 | 0.434 | 0.476 |
Stressful life events: Quartile 1= ≤1, Quartile 2= 2, Quartile 3= 3-4, Quartile 4= >4.
Model 1: Adjusted for Gail model score for breast cancer risk (age, race/ethnicity, age at menarche, age of the mother at the birth of her first live child, number of first-degree relatives with breast cancer, and the number of previous breast biopsy examinations), parity, body mass index, age at menopause, pack years of smoking, number of months breastfed, alcohol servings per week, total energy expenditure from recreational physical activity, annual family income, marital/relationship status, hormone therapy.
Model 2: Model 1+, depressive symptoms, social strain, social function
Abbreviations: 95%CI, 95% confidence interval; HR, hazard ratio; ER−, estrogen receptor negative, H=ER+, estrogen receptor positive; MET, metabolic equivalent of task
Note: Unopposed Hormone therapy usage includes unopposed estrogen and/or estrogen plus progesterone
We further assessed effect modification of stressful life events and ER-positive and ER-negative breast cancer by participant’s characteristics (Supplemental Table 2). In women with an income ranging $35,000 to $49,999, higher quartiles of stressful life events were associated with greater risk of ER-negative breast cancer when compared to the lowest quartile, albeit statistical significance was only observed for quartile 2 (Quartile 2 vs Quartile 1: HR=1.68; 95%CI 1.02–2.77) (P interaction <0.001). When stratifying by marital status, widowed women in the highest quartile of stressful life events had an increased risk of ER-negative breast cancer than those in the lowest quartile (Quartile 4 vs Quartile 1: HR=2.39; 95%CI 1.29–4.44) (P interaction <0.001). Finally, there was no statistically significant interaction for social strain on the relationship between stressful life events and breast cancer (P interaction=0.395). Moreover, social support did not modify the relationship between stressful life events and ER-positive and ER-negative breast cancer (Table 4).
Table 4.
Adjusted Hazard Ratios for the Association of Stressful Life Events and Incident Breast Cancer by Social Support and Estrogen Receptor Status in the Women’s Health Initiative, (n= 75,196)
| Stressful Life Events b | ||||||
|---|---|---|---|---|---|---|
|
| ||||||
| Incident breast cancer events | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P interaction | |
| HR (95%CI) a | HR (95%CI) | HR (95%CI) | HR (95%CI) | |||
| ER− | ||||||
| Social Support c | 0.473 | |||||
| Quartile 1 | 161 | Reference | 1.38 (0.85, 2.26) | 1.56 (0.92, 2.65) | 1.24 (0.73, 2.11) | |
| Quartile 2 | 147 | Reference | 1.06 (0.68, 1.64) | 0.82 (0.46, 1.47) | 1.66 (1.02, 2.72) | |
| Quartile 3 | 185 | Reference | 1.47 (0.98, 2.18) | 1.67 (1.05, 2.66) | 1.82 (1.12, 2.96) | |
| Quartile 4 | 141 | Reference | 1.10 (0.72, 1.67) | 0.77 (0.41, 1.43) | 0.73 (0.37, 1.44) | |
|
| ||||||
| ER+ | ||||||
| Social Support | 0.381 | |||||
| Quartile 1 | 977 | Reference | 0.90 (0.75, 1.08) | 0.85 (0.68, 1.05) | 1.03 (0.85, 1.25) | |
| Quartile 2 | 972 | Reference | 1.04 (0.88, 1.23) | 1.01 (0.82, 1.24) | 0.88 (0.71, 1.09) | |
| Quartile 3 | 1,161 | Reference | 1.15 (0.99, 1.33) | 1.03 (0.85, 1.24) | 0.93 (0.76, 1.15) | |
| Quartile 4 | 858 | Reference | 1.05 (0.89, 1.24) | 1.06 (0.85, 1.32) | 0.95 (0.73, 1.22) | |
Adjusted for Gail model score for breast cancer risk (age, race/ethnicity, age at menarche, age of the mother at the birth of her first live child, number of first-degree relatives with breast cancer, and the number of previous breast biopsy examinations), parity, body mass index, age at menopause, pack years of smoking, number of months breastfed, alcohol servings per week, total energy expenditure from recreational physical activity ,annual family income, marital/relationship status, hormone therapy, depressive symptoms, social strain, social function.
Stressful life events: Quartile 1= ≤1, Quartile 2= 2, Quartile 3= 3-4, Quartile 4= >4.
Social Support: Quartile 1= ≤32, Quartile 2= >32-≤37, and Quartile 3= >37-≤43, Quartile 4= >43.
Abbreviations: 95%CI, 95% confidence interval; HR, hazard ratio; MET, metabolic equivalent of task
Discussion
In this large cohort study of over 75,000 postmenopausal women, we identified differential associations in risk between stressful life events and incident breast cancer by ER status. Specifically, we demonstrated the contribution of higher stressful life events to increased risk of ER-negative breast cancer, while no association was observed for ER-positive breast cancer. We further observed no significant interaction for social support on the relationship between stressful life events and breast cancer ER status.
Our findings of a positive association between stressful life events and ER-negative breast cancer are consistent with evidence that suggested a relationship between social adversity and risk of ER-negative breast cancer (16,17,35). For instance, a descriptive epidemiologic study examined whether being born in a state with legal Jim Crow laws (legal discrimination practiced in twenty-one U.S. states and the District of Columbia) was associated with breast cancer ER status (17). The study observed higher odds of ER-negative tumors among Black woman born in a state when Jim Crow was legal (born before 1965) compared to Black women born in a non-Jim Crow state. Another study examined whether being born during the Great Chinese Famine (1959-1962) was associated with risk of breast cancer (16). The study results suggests that exposure to the Famine may increase likelihood of ER-negative breast cancer compared to women born after (after January 1, 1962) (16). These study findings are consistent with the present study, where higher experiences of stressful life events were associated with elevated risk of ER-negative breast cancer.
We demonstrate a relationship between stressful life events with ER-negative breast cancer and no association with ER-positive breast cancer. One potential explanation for our findings is attributed to alterations in mitochondrial function. Emerging evidence suggests that prolonged psychosocial stress can disrupt mitochondrial function resulting in stress-induced molecular changes and subsequent disease risk (36–40). Mitochondria, a subcellular organelle with its own genome, senses and responds to chronic psychosocial stress resulting in mitochondrial dysfunction and the production of reactive oxygen species with pro-tumorigenic effects.(36,40) Evidence suggests that mitochondrial biology is differential by breast cancer subtype and that dysfunction is higher in basal-like tumors in contrast to luminal A or ER-positive tumors (36,41). Nonetheless, further studies are needed to understand the biological mechanism between experiences of chronic psychosocial stress and increased risk of breast cancer by subtype. Interestingly, our results suggest an inverse association for ER-positive breast cancer among women experiencing higher stressful life events, though not statistically significant. Although additional research in this area is needed, previous studies have suggested that higher levels of chronic stress disrupt the hypothalamic–pituitary–adrenal axis, resulting in lower estradiol levels or chronic impairment of estrogen synthesis, potentially reducing ER-positive breast cancer among women at higher risk of estrogen-sensitive cancers (e.g., postmenopausal women) (42–44). Overall, our study adds to the limited body of literature describing the associations between lifetime stress and breast cancer risk by demonstrating an association between high psychosocial stress and increased risk of ER-negative breast cancer.
In our secondary analyses stratifying by participant characteristics, we observed the relationship between stress and ER-negative breast cancer varied by marital/relationship status. For instance, women who were widowed and in the highest quartile of stressful life events had an increased risk of ER-negative breast cancer. Previous studies have documented widowed individuals often report worse self-rated health, compromised biological function, and greater stress, all potential contributors to ER-negative breast cancer (45,46). We further observed that higher levels of stressful life events were more strongly associated with ER-negative breast cancer in women reporting lower household incomes, specifically those with annual incomes ranging $35,000 to $49,999. Prior studies have suggested that individuals of lower socioeconomic status are disproportionately exposed to social adversity and environmental factors that may contribute to increased risk of ER-negative breast cancer (16,30,47–49). Further, while the interaction was not statistically significant, we observed an elevated hazard for ER-negative breast cancer among women in the highest quartile of stressful life events reporting lower social support. Previous studies have suggested strong social support can buffer the deleterious effect psychosocial stress has on health, where lower social support has no influence (2,19,50).
The present study findings have important clinical and public health implications, given that ER-negative breast cancer is a more aggressive and harder to treat subtype compared with ER-positive breast cancer (51–53). Therefore, interventions are needed to prevent the risk of ER-negative breast cancer among women experiencing high psychosocial stress. Interventions can include clinicians screening for psychosocial stress in their assessment with the aim of providing referrals to resources that can help mitigate the adverse health effects.
The strengths of this study include being a large prospective cohort with extended follow-up time allowing for evaluation of breast cancer risk by ER status. The use of previously validated stressful life events which measures both the accumulation and perceptions of each major life events that occurred over the past year at study baseline. Additionally, stressful life events were measured prior to breast cancer diagnosis. Finally, breast cancer cases and corresponding ER status were confirmed using medical records and pathology reports that were centrally adjudicated, providing a more objective examination of the associations.
Several limitations must be noted. First, stressful life events were only measured at baseline, whereas repeat measures would have provided a more comprehensive understanding of the longitudinal role psychosocial stress has on incident breast cancer. Second, the stressful life events scale was used as a composite, where there is a chance that not all individual stressors assessed are equal. For instance, some stressors may be more impactful and detrimental to incident breast cancer than others. Third, given the prospective study design, any misclassification of self-reported stressful life events will lead to nondifferential misclassification, which tends to bias the association towards the null. Fourth, despite the Gail model’s attempt to develop race-specific risk calculations to obviate the need for race correction, the model does not account for socio-contextual factors known to affect risk that varies by race and ethnicity (e.g., socioeconomic position, social adversity) (27,28). Fifth, confounding variables were measured at baseline, resulting in potential misclassification due to lack of examination changes of these factors during follow-up. Sixth, the study included majority White women (83.5%), limiting the generalizability of our findings to other racial and ethnic groups and our ability to compare across groups. Finally, WHI solely includes older postmenopausal women; therefore, findings might not be generalizable to younger premenopausal women.
Conclusion
In this prospective analysis of postmenopausal women, experiencing higher stressful life events were associated with incident ER-negative breast cancer. Our findings provide evidence that high psychosocial stress can influence risk of ER-negative breast cancer, thereby potentially providing insight on why some groups are more likely to be diagnosed with this subtype than others. These results highlight the critical need to address the health implications of experiencing high psychosocial stress and to further explore social drivers of ER-negative breast cancer.
Supplementary Material
Prevention Relevance.
Epidemiologic studies on the association between psychosocial stress and breast cancer risk remain inconsistent, while investigation of whether the association differs by estrogen receptor (ER) status are limited. In this prospective cohort of postmenopausal women, high experiences of stressful life events were positively associated with ER-negative disease but not ER-positive.
Acknowledgments
The authors thank the other investigators, the staff, and the participants of the WHI study for their valuable contributions. A full list of participating WHI investigators and institutions can be found at https://www.whi.org/.
Funding/Support
This study was supported in part by the National Institutes of Health Intramural Research Program (W.R. Lawrence, F. Williams, M.S. Shiels, and N.D. Freedman). Additionally, Dr J.W. Magnani is supported by the National Institutes of Health K24HL160527 award; and Dr. J.A. McDonald is supported by the National Cancer Institute K01CA186943 and R01CA267897.
Role of the Funder/Sponsor
The funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, and the decision to submit the manuscript for publication. However, the funder did have final approval of the manuscript prior to submission.
Abbreviations
- ER
Estrogen Receptor
- WHI
Women’s Health Initiative
Footnotes
Conflict of Interest Disclosures
The authors declare no potential conflicts of interest
Code availability
The analytical methods for this study are available from the corresponding author upon appropriate request.
Disclaimer
The information presented by the authors is their own and this material should not be interpreted as representing the official viewpoint of the U.S. Department of Health and Human Services, the National Institutes of Health, the National Institute on Minority Health and Health Disparities, or the National Cancer Institute.
Data Availability
The full data set is stored at the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) at the National Heart, Lung, and Blood Institute (Bethesda, MD). The data is available for verification of these results with approval from the WHI Publications and Presentations committee and BioLINCC.
References
- 1.Bailey ZD, Williams DR. Stress, Health, and Disparities. In: Zigmond MJ, Rowland LP, Coyle JT, editors. Neurobiology of Brain Disorders. AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO: Elsevier; 2015. page 765–79. [Google Scholar]
- 2.Pascoe EA, Smart Richman L. Perceived discrimination and health: A meta-analytic review. Psychol Bull [Internet]. 2009;135:531–54. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/a0016059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barnes LL, de Leon CFM, Lewis TT, Bienias JL, Wilson RS, Evans DA. Perceived discrimination and mortality in a population-based study of older adults. Am J Public Health [Internet]. 2008;98:1241–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18511732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bowen D, Fernandez Poole S, White M, Lyn R, Flores D, Haile H, et al. The Role of Stress in Breast Cancer Incidence: Risk Factors, Interventions, and Directions for the Future. Int J Environ Res Public Health. 2021;18:1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nielsen NR, Grønbæk M. Stress and breast cancer: a systematic update on the current knowledge. Nat Clin Pract Oncol. 2006;3:612–20. [DOI] [PubMed] [Google Scholar]
- 6.Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012;9:360–70. [DOI] [PubMed] [Google Scholar]
- 7.Kershaw KN, Brenes GA, Charles LE, Coday M, Daviglus ML, Denburg NL, et al. Associations of Stressful Life Events and Social Strain With Incident Cardiovascular Disease in the Women’s Health Initiative. J Am Heart Assoc [Internet]. 2014;3. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.113.000687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Felix AS, Lehman A, Nolan TS, Sealy-Jefferson S, Breathett K, Hood DB, et al. Stress, Resilience, and Cardiovascular Disease Risk Among Black Women. Circ Cardiovasc Qual Outcomes [Internet]. 2019;12. Available from: https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.118.005284 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Duijts SFA, Zeegers MPA, Borne B Vd. The association between stressful life events and breast cancer risk: A meta-analysis. Int J Cancer. 2003;107:1023–9. [DOI] [PubMed] [Google Scholar]
- 10.Bahri N, Fathi Najafi T, Homaei Shandiz F, Tohidinik HR, Khajavi A. The relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies. Breast Cancer Res Treat. 2019;176:53–61. [DOI] [PubMed] [Google Scholar]
- 11.Petticrew M, Fraser JM, Regan MF. Adverse life-events and risk of breast cancer: A meta-analysis. Br J Health Psychol. 1999;4:1–17. [Google Scholar]
- 12.Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, et al. Influence of stressors on breast cancer incidence in the Women’s Health Initiative. Health Psychology [Internet]. 2009;28:137–46. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/a0012982 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Ann Intern Med. 2019;170:22–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Li C, Fan Z, Lin X, Cao M, Song F, Song F. Parity and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102050. [DOI] [PubMed] [Google Scholar]
- 15.Lambertini M, Santoro L, del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49:65–76. [DOI] [PubMed] [Google Scholar]
- 16.Alimujiang A, Mo M, Liu Y, Huang N, Liu G, Xu W, et al. The association between China’s Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study. Breast Cancer Res Treat [Internet]. 2016;160:361–9. Available from: http://link.springer.com/10.1007/s10549-016-3994-6 [DOI] [PubMed] [Google Scholar]
- 17.Krieger N, Jahn JL, Waterman PD. Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992–2012. Cancer Causes & Control [Internet]. 2017;28:49–59. Available from: http://link.springer.com/10.1007/s10552-016-0834-2 [DOI] [PubMed] [Google Scholar]
- 18.Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010;7:e1000316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cohen S Social Relationships and Health. American Psychologist. 2004;59:676–84. [DOI] [PubMed] [Google Scholar]
- 20.Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the Women’s Health Initiative study design. Ann Epidemiol [Internet]. 2003;13:S5–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14575938 [DOI] [PubMed] [Google Scholar]
- 21.Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS. Psychosocial Influences on Mortality after Myocardial Infarction. New England Journal of Medicine. 1984;311:552–9. [DOI] [PubMed] [Google Scholar]
- 22.Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705–14. [DOI] [PubMed] [Google Scholar]
- 23.Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83. [PubMed] [Google Scholar]
- 24.Rook KS. The negative side of social interaction: Impact on psychological well-being. J Pers Soc Psychol. 1984;46:1097–108. [DOI] [PubMed] [Google Scholar]
- 25.Karim J, Weisz R, Bibi Z, ur Rehman S. Validation of the Eight-Item Center for Epidemiologic Studies Depression Scale (CES-D) Among Older Adults. Current Psychology. 2015;34:681–92. [Google Scholar]
- 26.Krieger N Theoretical frameworks and cancer inequities. In: Vaccarella S, Lortet-Tieulent J, Saracci R, Conway D, Straif K, Wild C, editors. Reducing social inequalities in cancer: evidence and priorities for research. 1st ed. Lyon: WHO Press; 2019. page 111–7. [Google Scholar]
- 27.Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for Chemoprevention. JNCI Journal of the National Cancer Institute [Internet]. 2001;93:358–66. Available from: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/93.5.358 [DOI] [PubMed] [Google Scholar]
- 28.Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst [Internet]. 2007;99:1782–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18042936 [DOI] [PubMed] [Google Scholar]
- 29.Curb JD, Mctiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the women’s health initiative. Ann Epidemiol. 2003;13:S122–8. [DOI] [PubMed] [Google Scholar]
- 30.Krieger N. History, Biology, and Health Inequities: Emergent Embodied Phenotypes and the Illustrative Case of the Breast Cancer Estrogen Receptor. Am J Public Health [Internet]. 2013;103:22–7. Available from: http://ajph.aphapublications.org/doi/10.2105/AJPH.2012.300967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Cohen S, Murphy MLM, Prather AA. Ten Surprising Facts About Stressful Life Events and Disease Risk. Annu Rev Psychol. 2019;70:577–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clinical Practice and Epidemiology in Mental Health. 2007;3:29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wu Chou AI, Wang Y-C, Lin C-L, Kao C-H. Female schizophrenia patients and risk of breast cancer: A population-based cohort study. Schizophr Res. 2017;188:165–71. [DOI] [PubMed] [Google Scholar]
- 34.Howard LM, Barley EA, Davies E, Rigg A, Lempp H, Rose D, et al. Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol. 2010;11:797–804. [DOI] [PubMed] [Google Scholar]
- 35.Lord BD, Harris AR, Ambs S. The impact of social and environmental factors on cancer biology in Black Americans. Cancer Causes & Control. 2022; 10.1007/s10552-022-01664-w. [DOI] [PubMed] [Google Scholar]
- 36.Sarmiento-Salinas FL, Delgado-Magallón A, Montes-Alvarado JB, Ramírez-Ramírez D, Flores-Alonso JC, Cortés-Hernández P, et al. Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment. Front Oncol [Internet]. 2019;9. Available from: https://www.frontiersin.org/article/10.3389/fonc.2019.00480/full [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Meyer T, Wirtz PH. Mechanisms of Mitochondrial Redox Signaling in Psychosocial Stress-Responsive Systems: New Insights into an Old Story. Antioxid Redox Signal. 2018;28:760–72. [DOI] [PubMed] [Google Scholar]
- 38.Picard M, McEwen BS. Psychological Stress and Mitochondria: A Systematic Review. Psychosom Med [Internet]. 2018;80:141–53. Available from: https://journals.lww.com/00006842-201802000-00003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Daniels TE, Olsen EM, Tyrka AR. Stress and Psychiatric Disorders: The Role of Mitochondria. Annu Rev Clin Psychol. 2020;16:165–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Picard M, McEwen BS. Psychological Stress and Mitochondria: A Conceptual Framework. Psychosom Med. 2018;80:126–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ortega-Lozano AJ, Gómez-Caudillo L, Briones-Herrera A, Aparicio-Trejo OE, Pedraza-Chaverri J. Characterization of Mitochondrial Proteome and Function in Luminal A and Basal-like Breast Cancer Subtypes Reveals Alteration in Mitochondrial Dynamics and Bioenergetics Relevant to Their Diagnosis. Biomolecules. 2022;12:379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Antonova L, Aronson K, Mueller CR. Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Research. 2011;13:208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Melhem-Bertrandt A, Conzen SD. The Relationship Between Psychosocial Stressors and Breast Cancer Biology. Curr Breast Cancer Rep. 2010;2:130–7. [Google Scholar]
- 44.Nielsen NR, Zhang Z-F, Kristensen TS, Netterstr⊘m B, Schnohr P, Gr⊘nbæk M. Self reported stress and risk of breast cancer: prospective cohort study. BMJ. 2005;331:548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rote S Marital Disruption and Allostatic Load in Late Life. J Aging Health. 2017;29:688–707. [DOI] [PubMed] [Google Scholar]
- 46.Williams BR, Sawyer P, Roseman JM, Allman RM. Marital Status and Health: Exploring Pre-Widowhood. J Palliat Med. 2008;11:848–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of Health Disparities in Relation to the Biology of Estrogen Receptor–Negative Breast Cancer. Semin Oncol [Internet]. 2010;37:384–401. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0093775410000679 [DOI] [PubMed] [Google Scholar]
- 48.Liu R, Nelson DO, Hurley S, Hertz A, Reynolds P. Residential exposure to estrogen disrupting hazardous air pollutants and breast cancer risk: the California Teachers Study. Epidemiology. 2015;26:365–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wallace TA, Martin DN, Ambs S. Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis. 2011;32:1107–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Cacioppo JT, Hawkley LC, Norman GJ, Berntson GG. Social isolation. Ann N Y Acad Sci. 2011;1231:17–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Davis Lynn BC, Chernyavskiy P, Gierach GL, Rosenberg PS. Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region. JNCI: Journal of the National Cancer Institute. 2022;114:263–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Daly B, Olopade OI. A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin [Internet]. 2015;65:221–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25960198 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated during this study may be made available upon appropriate request from the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) at the National Heart, Lung, and Blood Institute (Bethesda, MD). Additionally, the analytical methods for this study are available from the corresponding author upon appropriate request.
The full data set is stored at the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) at the National Heart, Lung, and Blood Institute (Bethesda, MD). The data is available for verification of these results with approval from the WHI Publications and Presentations committee and BioLINCC.
